Olgram

Olgram is a biotechnology company developing first-in-class, proprietary immunotherapies to treat immune deficiencies, beginning with immuno-oncology and infectious diseases. They develop molecules and an associated biomarker to cure immune diseases after a traumatic brain injury and new anti-infectives to cure chronic infections by destroying the bacteria at the root of the relapses.